NovaBay Pharmaceuticals Inc.
01/30/2026 | Press release | Distributed by Public on 01/30/2026 16:09
Change in Certifying Accountants (Form 8-K)
Item 4.01. Changes in Registrant's Certifying Accountant.
On January 30, 2026, with the approval of the Audit Committee, CBIZ CPAs, P.C. ("CBIZ") was engaged as the Company's new independent registered public accounting firm for the fiscal year ending December 31, 2025.
During the fiscal years ended December 31, 2025 and 2024 and the subsequent interim period through January 30, 2026, neither the Company nor anyone on its behalf consulted with CBIZ regarding:
|
(i)
|
the application of accounting principles to a specified transaction, completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements, and neither a written report nor oral advice was provided to the Company that CBIZ concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue; or
|
|
(ii)
|
any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) or a reportable event (as described in Item 304(a)(1)(v) of Regulation S-K).
|
Item 8.01. Other Events.
NovaBay Pharmaceuticals, Inc. (the "Company") will hold a special meeting of stockholders of the Company on March 12, 2026 at 11:00 a.m. Eastern Time (the "Special Meeting"), at which stockholders will be asked to vote on, among other corporate actions, proposals approving the issuance of the Company's common stock upon the exercise of the pre-funded warrants that were issued in our private placement transactions on each of January 16, 2026 and October 16, 2025.
NovaBay Pharmaceuticals Inc. published this content on January 30, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on January 30, 2026 at 22:09 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]